Biomind Labs Inc (TSE:BMND)
NEO-L:BMND

Biomind Labs Inc (BMND) Stock Price & Analysis

3 Followers

BMND Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.12 - C$0.12
Previous CloseC$0.12
Volume0.00
Average Volume (3M)N/A
Market Cap
C$1.15M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)
BetaN/A
Aug 13, 2024
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Options Prices

Currently, No data available
---

Ownership Overview

31.46%0.00%0.00%68.54%
31.46%
Insiders
0.00% Other Institutional Investors
68.54% Public Companies and
Individual Investors

BMND FAQ

What was Biomind Labs Inc’s price range in the past 12 months?
Biomind Labs Inc lowest stock price was C$0.12 and its highest was C$0.12 in the past 12 months.
    What is Biomind Labs Inc’s market cap?
    Currently, no data Available
    When is Biomind Labs Inc’s upcoming earnings report date?
    Biomind Labs Inc’s upcoming earnings report date is Aug 13, 2024 which is in 19 days.
      How were Biomind Labs Inc’s earnings last quarter?
      Biomind Labs Inc released its earnings results on May 31, 2024. The company reported -C$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.003.
        Is Biomind Labs Inc overvalued?
        According to Wall Street analysts Biomind Labs Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Biomind Labs Inc pay dividends?
          Biomind Labs Inc pays a Notavailable dividend of C$1.82 which represents an annual dividend yield of N/A. See more information on Biomind Labs Inc dividends here
            What is Biomind Labs Inc’s EPS estimate?
            Biomind Labs Inc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Biomind Labs Inc have?
            Biomind Labs Inc has 74,761,856 shares outstanding.
              What happened to Biomind Labs Inc’s price movement after its last earnings report?
              Biomind Labs Inc reported an EPS of -C$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Biomind Labs Inc?
                Currently, no hedge funds are holding shares in TSE:BMND
                ---

                Biomind Labs Inc Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                0.00%
                12-Months-Change

                Fundamentals

                Return on Equity
                Trailing 12-Months
                Asset Growth
                -5.46%
                Trailing 12-Months
                Similar Stocks
                Company
                Price & Change
                Follow
                Tetra Bio-Pharma
                Biosyent
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis